A new model of bioterrorism risk assessment

Biosecurity and Bioterrorism

Volumn 7, Issue 4, 2009, Pages 443-451

  Radosavljevic, Vladan ^a   Belojevic, Goran ^b  

^a Military Institute of Preventive Medicine   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL WARFARE; METHODOLOGY; NONBIOLOGICAL MODEL; REVIEW; RISK ASSESSMENT; UNITED STATES;

BIOTERRORISM; MODELS, ORGANIZATIONAL; RISK ASSESSMENT; UNITED STATES;

EID: 77749298671     PISSN: 15387135     EISSN: None     Source Type: Journal    
DOI: 10.1089/bsp.2009.0016     Document Type: Review

References (47)

1. Committee on Methodological Improvements to the Department of Homeland Security's Biological Agent Risk Analysis, National Research Council. Department of Homeland Security Bioterrorism Risk Assessment: A Call for Change. Washington, DC: National Academies Press; 2008. http://www.nap.edu/ catalog.php?record-id=12206. Accessed November 19, 2009.
2. Parnell GS, Borio LL, Brown GG, Banks D, Wilson AG. Scientists urge DHS to improve bioterrorism risk assessment. Biosecur Bioterror 2008;6(4):1-4.
3. Zilinskas AR, Hope B, North WD. A discussion of findings and their possible implications from a workshop on bio-terrorism threat assessment and risk management. Risk Anal 2004;24:901-908.
4. Bossi P, Bricaire F. Biological weapons. Cell Mol Life Sci 2006;63:2193-2195.
5. Bossi P, Garin D, Guihot A, et al. Bioterrorism: management of major biological agents. Cell Mol Life Sci 2006; 63:2196-2212.
6. Karwa M, Currie B, Kvetan V. Bioterrorism: preparing for the impossible and the improbable. Crit Care Med 2005;33: S75-S95.
7. Tegnell A, Van Loock F, Baka A, et al. Development of a matrix to evaluate the threat of biological agents used for bioterrorism. Cell Mol Life Sci 2006;63:2223-2228.
8. May T, Silverman R. Bioterrorism defense priorities. Science 2003;301:17.
9. Lam C, Franco C, Schuler A. Billions for biodefense: federal agency biodefense funding, FY2006-FY2007. Biosecur Bio-terror 2006;4:113-127.
10. Zilinskas RA, Carus WS. Possible Terrorist Use of Modern Biotechnology Techniques. Washington, DC: Chemical and Biological Defense Information Analysis Center; 2002.
11. Laqueur W. Postmodern terrorism. Foreign Aff 1996; Sep/Oct.
12. Radosavljević V, Jakovljević B. Bioterrorism - types of epidemics, new epidemiological paradigm and levels of prevention. Public Health 2007;121:549-557.
13. U.S. Centers for Disease Control and Prevention. Bio-terrorism Agents/Diseases 2007. www.bt.cdc.gov/agent/agentlist-category.asp. Accessed November 19, 2009.
14. Pappas G, Panagopoulou P, Christou L, et al. Category B potential bioterrorism agents: bacteria, viruses, toxins, and foodborne and waterborne pathogens. Infect Dis Clin North Am 2006;20:395-421.
15. Mushtaq A, El-Azizi M, Khardori N. Category C potential bioterrorism agents and emerging pathogens. Infect Dis Clin North Am 2006;20:423-441.
16. Mayor S. UK doctors warned after ricin poison found in police raid. Br Med J 2003;326:126.
17. Patočka J, Strěda L. Plant toxic proteins and their current significance for warfare and medicine. J Appl Biomed 2003;1:141-147.
18. Steinbrook R. Biomedical research and biosecurity. New Engl J Med 2005;353:2212-2214.
19. Ebright RH, Connell ND. Bioweapon agents: more access means more risk. Nature 2002;415:364.
20. Bhattacharjee Y. US panel wants security rules applied to genomes, not pathogens. Science 2006;314:743.
21. Check E. Poliovirus advance sparks fears of data curbs. Nature 2002;418:265.
22. Carr K, Henchal E, Wilhelmsen C, et al. Implementation of biosurety systems in a Department of Defense medical research laboratory. Biosecur Bioterror 2004;2:7-16.
23. Check E. Synthetic biologists face up to security issues. Nature 2005;436:894.
24. Broad W, Miller J. The threat of germ weapons is rising. Fear, too. New York Times December 27, 1998.
25. Siegrist DW. The threat of biological attack: why concern now? Emerg Infect Dis 1999;5:505-508.
26. Hartley DM, Peters CJ. Aerosols from insect control measures show dangers of bioterrorism. Biosecur Bioterror 2003;1:221-222.
27. Sobel J, Khan AS, Swerdlow DL. Threat of a biological terrorist attack on the US food supply: the CDC perspective. Lancet 2002;359:874-880.
28. Khardori N. Bioterrorism and bioterrorism preparedness: historical perspective and overview. Infect Dis Clin North Am 2006;20:179-211.
29. Kaufmann AF, Meltzer MI, Schnid GP. The economic impact of a bioterrorist attack: are prevention and post attack intervention programs justifiable? Emerg Infect Dis 1997;3: 83-94.
30. Hughes D. World's airlines face an elusive foe in SARS. Aviation Week and Space Technology April 28, 2003.
31. World M. Bioterrorism: the need to be prepared. Clin Med 2004;4:161-164.
32. Guillemin J. Biological weapons and secrecy. FASEB J 2005;19:1763-1765.
33. Beuchat LR, Ryu JH. Produce handling and processing practices. Emerg Infect Dis 1997;3:459-465.
34. Kowalski W, Bahnfleth W, Musser A. Modeling immune building systems for bioterrorism defense. J Architectural Engineering 2003;9:86-96.
35. U.S. Centers for Disease Control and Prevention. Update: adverse events following civilian smallpox vaccination - United States. MMWR Morb Mortal Wkly Rep 2003;53: 106-107.
36. Tucker JB. Biosecurity: limiting terrorist access to deadly pathogens. Peaceworks 52 November 2003. United States Institute of Peace. http://www.usip.org/resources/biosecurity-limiting-terrorist-access-deadly- pathogens. Accessed November 19, 2009. 37. U.S. Senate Committee on Banking, Housing and Urban Affairs. United States dual-use exports to Iraq and their impact on the health of the Persian Gulf War Veterans. 103rd Congress, 2nd session. 1994.
37. Inglesby TV, Henderson DA, Bartlett JG, et al. Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 1999;281: 1735-1745.
38. Zilinskas AR. Bioterrorism Threat Assessment and Risk Management. Monterey, CA: Center for Nonproliferation Studies, Monterey Institute of International Studies; 2003. http://cns.miis.edu/pubs/reports/pdfs/biorisk.pdf. Accessed November 19, 2009.
39. Alberts B. Modeling attacks on the food supply. Proc Natl Acad Sci U S A 2005;102:9737-9738.
40. Wein LM, Liu Y. Analyzing a bioterror attack on the food supply: the case of botulinum toxin in milk. Proc Natl Acad Sci U S A 2005:102:9984-9989.
41. Rotz LD, Khan AS, Lillibridge SR, et al. Public health assessment of potential biological terrorism agents. Emerg Infect Dis 2002;8:225-230.
42. Nuzzo J. The biological threat to U.S. water supplies: toward a national water security policy. Biosecur Bioterror 2006;4: 147-159.
43. Burrows WD, Renner SE. Biological warfare agents as threats to potable water. Environ Health Perspect 1999;107: 975-984.
44. MacKenzie WR, Schell WL, Blair KA, et al. Massive outbreak of waterborne cryptosporidium infection in Milwaukee, Wisconsin: recurrence of illness and risk of secondary transmission. Clin Infect Dis 1995;21:57-62.
45. Schultz CH. Chinese curses, anthrax, and the risk of bio-terrorism. Ann Emerg Med 2004;43(3):329-332.
46. Khan AS, Morse S, Lillibridge S. Public-health preparedness for biological terrorism in the USA. Lancet 2000;356: 1179-1182.
47. Ferguson NM, Keeling MJ, Edmunds WJ, et al. Planning for smallpox outbreaks. Nature 2003;425(6959):681-685.